Article Details
Retrieved on: 2018-11-23 18:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its holdings in Sorrento Therapeutics by 20.6% during the third quarter. <b>Vanguard Group</b> Inc. now owns 5,421,877 shares ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here